...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Retraction: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
【24h】

Retraction: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.

机译:撤回:评估结肠癌特异性抗原2作为结直肠癌的潜在血清标志物。

获取原文
获取原文并翻译 | 示例

摘要

The authors wish to retract the article entitled "Evaluation of Colon Cancer-Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer," which was published in the March 1, 2008, issue of Clinical Cancer Research. As the authors re-reviewed the data presented in the article, they identified differences between some of the plate reader values and those that were reported in the article. For some of the data, the values were indeed from the plate reader data, whereas the source of other values was not apparent. Therefore, the authors believe that the article may contain data falsification. Furthermore, the values were not blanked. The authors feel that the inconsistencies in the data collection and recordation warrant retraction of the article. Five of the 6 authors of the original article agreed to this Retraction. Attempts on the part of the journal office to contact the first author, Eddy S. Leman, were unsuccessful.
机译:作者希望撤回发表在2008年3月1日的《临床癌症研究》上的标题为“结肠癌特异抗原2作为潜在的血清标志物的评估”的文章。当作者重新审阅文章中提供的数据时,他们发现了一些读板器值与文章中报道的值之间的差异。对于某些数据,这些值确实来自酶标仪数据,而其他值的来源并不明显。因此,作者认为该文章可能包含数据伪造。此外,这些值未空白。作者认为,数据收集和记录中的不一致应撤消本文。原始文章的6位作者中有5位同意此撤稿。期刊办公室尝试与第一作者Eddy S. Leman联系,但未成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号